Circulating microRNA-203a is a novel biomarker for bone loss and response to anabolic therapy with PTH.

被引：0
|
作者：
Kocijan, Roland [1 ]
Geiger, Elisabeth [2 ]
Skalicky, Susanna [2 ]
Weigl, Moritz [2 ]
Leinfellner, Gabriele [3 ]
Ferguson, James [3 ]
Heimel, Patrick [3 ]
Redl, Heinz [3 ]
Grillari, Johannes [4 ]
Hackl, Matthias [2 ]
机构：
[1] Med Univ Vienna, Acad Teaching Hosp, VINFORCE Study Grp, St Vincent Hosp,Med Dept 2, Vienna, Austria
[2] TAmiRNA GmbH, Vienna, Austria
[3] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria
[4] BOKU Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SU0095
引用
收藏
页码：S210 / S211
页数：2
相关论文
共 15 条
  • [1] Chronic subcutaneous, but not single intravenous dosing of rats with bisphosphonates results in reduced bone anabolic response to PTH.
    Gasser, Juerg A.
    Ingold, Peter
    Venturiere, Andrea
    Green, Jonathan R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S589 - S589
  • [2] Chronic subcutaneous, but not single intravenous dosing of rats with bisphosphonates results in reduced bone anabolic response to PTH.
    Gasser, J. A.
    Ingold, P.
    Venturiere, A.
    Green, J. R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S113 - S113
  • [3] Impaired Bone Anabolic Response to PTH Therapy in the Th3/+ Mouse Model of Thalassemia.
    Tsay, J.
    Grady, R. W.
    Giardina, P. J.
    Boskey, A. L.
    Vogiatzi, M. G.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [4] Strain-Specific Response of Inbred Mice to PTH Suggests Significant Genetic Control of the Bone Anabolic Response to Drug Therapy
    Adams, Douglas
    Hart, Olivia
    Rydzik, Renata
    Godfrey, Dana
    Zuscik, Michael
    Ackert-Bicknell, Cheryl
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 117 - 117
  • [5] MicroRNA-21 as a novel biomarker in diagnosis and response to therapy in asthmatic children
    Elbehidy, Rabab M.
    Youssef, Doaa M.
    El-Shal, Amal S.
    Shalaby, Sally M.
    Sherbiny, Hanan S.
    Sherief, Laila M.
    Akeel, Nagwa E.
    MOLECULAR IMMUNOLOGY, 2016, 71 : 107 - 114
  • [6] Intermittent PTH administration: A novel therapy method for periodontitis-associated alveolar bone loss
    Liu, Jianbo
    Cao, Zhengguo
    Li, Chengzhang
    MEDICAL HYPOTHESES, 2009, 72 (03) : 294 - 296
  • [7] Circulating cell-free DNA - A novel biomarker for response to therapy in ovarian carcinoma
    Kamat, Aparna A.
    Bischoff, Farideh Z.
    Dang, Dianne
    Baldwin, Matthew F.
    Han, Liz Y.
    Lin, Yvonne G.
    Merritt, William M.
    Landen, Charles N.
    Lu, Chunhua
    Gershenson, David M.
    Simpson, Joe L.
    Sood, Anil K.
    CANCER BIOLOGY & THERAPY, 2006, 5 (10) : 1369 - 1374
  • [8] Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy
    Sinha, Partha
    Aarnisalo, Piia
    Chubb, Rhiannon
    Poulton, Ingrid J.
    Guo, Jun
    Nachtrab, Gregory
    Kimura, Takaharu
    Swami, Srilatha
    Saeed, Hamid
    Chen, Min
    Weinstein, Lee S.
    Schipani, Ernestina
    Sims, Natalie A.
    Kronenberg, Henry M.
    Wu, Joy Y.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (04) : 1631 - 1642
  • [9] Circulating cell-free DNA: a novel surrogate biomarker for response to therapy in an ovarian cancer model
    Kamat, Aparna A.
    Bischoff, Farideh Z.
    Dang, Dianne
    Han, Liz
    Landen, Charles N., Jr.
    Lin, Yvonne
    Merritt, William
    Gershenson, David M.
    Simpson, Joe L.
    Sood, Anil K.
    CANCER RESEARCH, 2006, 66 (08)
  • [10] Serum exosomal microRNA-199b-5p as a novel circulating biomarker to predict response of preoperative chemoradiotherapy for locally advanced rectal cancer
    Baek, D. W.
    Cho, H. J.
    Baek, J. H.
    Lee, S. J.
    Kang, B. W.
    Chae, Y. S.
    Kim, J. G.
    ANNALS OF ONCOLOGY, 2019, 30
12